Clinical Trial Update: PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma. [Phase 1]

View source ↗

Summary

Clinical trial update on a PD-1 mRNA lipid nanoparticle vaccine being tested for advanced hepatocellular carcinoma; Phase 1 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1 mRNA LNP vaccine (PD-1 mRNA lipid nanoparticle vaccine)

Snippet

Sponsor: West China Hospital | Conditions: Liver Cancer | Phase 1 | Status: RECRUITING